Generation of replication-competent hepatitis B virus nucleocapsids in insect cells

被引:29
|
作者
Seifer, M [1 ]
Hamatake, R [1 ]
Bifano, M [1 ]
Standring, DN [1 ]
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Wallingford, CT 06492 USA
关键词
D O I
10.1128/JVI.72.4.2765-2776.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The double-stranded DNA genome of human hepatitis B virus (HBV) and related hepadnaviruses is reverse transcribed from a pregenomic RNA by a viral polymerase (Pol) harboring both priming and RNA-and DNA-dependent elongation activities, Although hepadnavirus replication occurs inside viral nucleocapsids, or cores, biochemical systems for analyzing this reaction are currently limited to unencapsidated Pols expressed in heterologous systems, Here, we describe cis and trans classes of replicative HBV cores, produced in the recombinant baculovirus system via coexpression of HBV core and Pol proteins from either a single RNA (i.e,, in cis) or two distinct RNAs (in trans), Upon isolation from insect cells, cis and trans cores contained Pol-linked HBV minus-strand DNA with 5' ends mapping to the authentic elongation origin DR1 and also plus-strand DNA species, Only trans cores, however, were highly active for the de novo priming and reverse transcription of authentic HBV minus strands in in vitro endogenous polymerase assays, This reaction strictly required HBV Pol but not the epsilon stem-loop element, although the presence of one epsilon, or better, two epsilon s, enhanced minus-strand synthesis up to 10-fold, Compared to unencapsidated Pol enzymes, encapsidated Pol appeared to be (i) highly processive, able to extend minus-strand DNAs of 400 nucleotides from DR1 in vitro, and (ii) more active for HBV plus-strand synthesis. These observations suggest possible contributions to the replication process from the HBV core protein. These novel core reagents should facilitate the analysis of HBV replication in its natural environment, the interior of the capsid, and also fuel the development of new anti-HBV drug screens.
引用
收藏
页码:2765 / 2776
页数:12
相关论文
共 50 条
  • [41] Comparison of the oncolytic activity of a replication-competent and a replication-deficient herpes simplex virus 1
    Lindner, Georg
    Walter, Annika
    Magnus, Clara L.
    Rosenhammer, Katharina
    Holoborodko, Bohdan
    Koch, Victoria
    Hirsch, Sarah
    Grossmann, Luis
    Li, Suqi
    Knipe, David M.
    Deluca, Neal
    Schuler-Thurner, Beatrice
    Gross, Stefanie
    Schwertner, Barbara
    Toelge, Martina
    Rohrhofer, Anette
    Stoeckl, Sabine
    Bauer, Richard J.
    Knoll, Gertrud
    Ehrenschwender, Martin
    Haferkamp, Sebastian
    Schmidt, Barbara
    Schuster, Philipp
    IMMUNOLOGY, 2024, 172 (02) : 279 - 294
  • [42] Generation of the replication-competent human immunodeficiency virus type 1 which expresses a jellyfish green fluorescent protein
    Lee, AH
    Han, JM
    Sung, YC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) : 288 - 292
  • [43] Identification of a LIF-Responsive, Replication-Competent Subpopulation of Human β Cells
    Rosado-Olivieri, Edwin A.
    Aigha, Idil I.
    Kenty, Jennifer H.
    Melton, Douglas A.
    CELL METABOLISM, 2020, 31 (02) : 327 - +
  • [44] Generation and Characterization of a Replication-Competent Human Adenovirus Type 55 Encoding EGFP
    Li, Wei
    Chen, Yuehong
    Feng, Ye
    Li, Jing
    Kang, Xiaoping
    Zhang, Sen
    Li, Yuchang
    Zhao, Zhiyan
    Yang, Wenguang
    Zhao, Lu
    Wang, Huiyao
    Jiang, Tao
    VIRUSES-BASEL, 2023, 15 (05):
  • [45] Replication-competent viral vectors for delivery of the next generation of HIV vaccine candidates
    Dean, Hansi
    Zamb, Tim
    Parks, Chris
    HUMAN GENE THERAPY, 2008, 19 (10) : 1068 - 1069
  • [46] Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
    Yuanyuan Jiang
    Boya Zhong
    Kiyoko Kawamura
    Takao Morinaga
    Masato Shingyoji
    Ikuo Sekine
    Yuji Tada
    Koichiro Tatsumi
    Hideaki Shimada
    Kenzo Hiroshima
    Masatoshi Tagawa
    BMC Cancer, 16
  • [47] Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing
    Cornetta, Kenneth
    Lin, Tsai-Yu
    Pellin, Danilo
    Kohn, Donald B.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 28 : 28 - 39
  • [48] Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
    Jiang, Yuanyuan
    Zhong, Boya
    Kawamura, Kiyoko
    Morinaga, Takao
    Shingyoji, Masato
    Sekine, Ikuo
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    Tagawa, Masatoshi
    BMC CANCER, 2016, 16
  • [49] NOVEL REPLICATION-COMPETENT HERPES SIMPLEX VIRUS AND THERAPY OF EXPERIMENTAL GLIOBLASTOMA MULTIFORME
    Hadjipanayis, Costas
    Machaidze, Revaz
    Van Meir, Erwin
    Deluca, Neal
    NEURO-ONCOLOGY, 2008, 10 (05) : 794 - 794
  • [50] Properties and use of novel replication-competent vectors based on Semliki Forest virus
    Kai Rausalu
    Anna Iofik
    Liane Ülper
    Liis Karo-Astover
    Valeria Lulla
    Andres Merits
    Virology Journal, 6